Thursday, February 13, 2014

Genes And Early Americans

An article by Morten Rasmussen et al., published in the February 13, 2014, issue of the journal Nature  suggests that all Native Americans are descended from the same small group of ancestors.  Entitled The genome of a Late Pleistocene human from a Clovis burial site in western Montana, the article describes the results of sequencing DNA from an infant boy ("Anzick-1") who was buried in Wyoming more than10,000 years ago.  As the article explains,
The Anzick-1 data...serves to unify the genetic and archaeological records of early North America, it is consistent with a human occupation of the Americas a few thousand years before Clovis, and demonstrates that contemporary Native Americans are descendants of the first people to settle successfully in the Americas. [Footnotes omitted.]
Because the remains of Anzick-1 were found on private land, the federal Native American Graves Protection and Repatriation Act ("NAGPRA") was not triggered.  The NAGPRA requires that ancient human remains found on federal property be returned to whichever Native American tribe has the closest "cultural affiliation" with those remains.  Section 2(2) of NAGPRA defines "cultural affiliation" as
a relationship of shared group identity which can be reasonably traced historically or prehistorically between a present day Indian tribe or Native Hawaiian organization and an identifiable earlier group.
A number of Native American tribes in Wyoming have expressed cultural affiliation with Anzick-1.  Having shed remarkable light on Native American origins, he should be reburied with respect and honor.

Friday, February 7, 2014

China: Patent Superpower

The World Intellectual Property Office ("WIPO") has heralded what may be a new age of Chinese patent predominance, noting, among many other things, that
The 2013 edition of the World Intellectual Property Indicators also shows that for the first time, China tops the ranking for both the source (filings by China) and the destination (filed in China) for the four types of IP (patents, utility models, trademarks and industrial designs). Of the top five IP offices worldwide, the State Intellectual Property Office of the People’s Republic of China (SIPO) was alone in recording double-digit growth for each of the four types of IP. Continued rapid filing growth in China is the main driver of global IP growth.

As China increases its emphasis on patent filings, both at home and abroad, its patent culture is sure to evolve towards stronger enforcement of patent rights.  Although this has long been viewed by the West as "a consummation/ Devoutly to be wish'd," the arrival of a patent-assertive China may become a mixed blessing for countries that previously dominated the patent league tables.  For, their companies may increasinging be named as defendants in patent infringement suits filed by Chinese patent owners.  "[A]y, there's the rub."

Islands Off The Grid

The Virgin Islands, both United States and British, are among the most beautiful places on earth.  This has not gone unnoticed by the wealthy.  Following in the sandy footsteps of Cornings and Rockefellers, modern moguls have acquired their own personal paradises there.

British magnate Richard Branson owns gorgeous Necker Island.  On February 5, 2014, he announced his intention to move Necker Island towards self-sufficiency by developing its own alternative energy sources, such as solar and wind power, which are perennially abundant in the Virgin Islands.  Although likely to be expensive, Branson's efforts have the potential to offer proof of green energy concept to other small islands throughout the world.  This could have the additional salutary benefit of reducing the air and water pollution from fossil fuel power generation that clashes with the natural beauty, and harms the abundant biodiversity, of islands in the stream.

Friday, January 31, 2014

Strategic Keystone

If the proposed Keystone XL oil pipeline through the United States is not built, Canada is likely to redirect massive quantities of oil from its Alberta tar sands to China.  Proven oil reserves in Canada - largely Alberta - rival those of Saudi Arabia.  Losing access to them would be perceived by many in the U.S. as a strategic disaster.  Losing them to growing rival China would perceived as far worse.

Enter the environmental impact assessment process mandated by the U.S. National Environmental Policy Act ("NEPA") in the case of major federal actions.  President Barack Obama stated on July 27, 2013, that
I'm going to evaluate this [proposed Keystone XL pipeline] based on whether or not this is going to significantly contribute to carbon in our atmosphere.
On January 31, 2014, the U.S. Department of State released its Final Supplemental Environmental Impact Statement ("FSEIS") on the pipeline.  Section 1.4 of the FSEIS includes analysis of President Obama's evaluation criterion:
Approval or denial of any one crude oil transport project, including the proposed Project, remains unlikely to significantly impact the rate of extraction in the oil sands...
In other words, according to the FSEIS, approval of the Keystone XL pipeline will be essentially irrelevant to the amount of "carbon in our atmosphere." So, will the United States or China be directly responsible for releasing that carbon?  Based on the the State Department's FSEIS, it is now much likelier to be Canada's fossil fuel-hungry neighbor to the south.

Thursday, January 30, 2014

Potent Patent Portfolios

Once a leading technology firm, Motorola Mobility, through its sale to Lenovo, has now completed its transformation from a hardware company, to a provider of Android platforms, and, finally, to a pure, yet powerful, portfolio of patents.  Which of these incarnations is the most valuable?  The patent portfolio has, because it has given Google some measure of legal security among the robust patent holdings of competitors like Apple, Microsoft, and Amazon.  Like a aircraft carrier purchased for the salvage value of its copper wire, Motorola Mobility is now being stripped down for its intellectual property.  For many companies, that is increasingly where their only true value lies.

Monday, January 27, 2014

Grand Patent Alliance

Two of the main combatants in the global patent war that has been raging over the past few years in the mobile/tablet industry have reached an intellectual property détente.  On January 26, 2014, technology titans Samsung and Google announced a grand cross-licensing deal that eliminates current, and avoids future, patent disputes.  Here is an excerpt from the Samsung announcement:
Samsung Electronics Co., Ltd. and Google Inc. today furthered their long-term cooperative partnership with a global patent cross-license agreement covering a broad range of technologies and business areas. The mutually beneficial agreement covers the two companies’ existing patents as well as those filed over the next 10 years.
This deal may relieve some of the competitive pressure facing Google after the September 29, 2011, patent treaty agreed between Samsung and Microsoft.  As in any world war, alliances between former combatants can decisively tip the strategic balance from disadvantage to victory.  More patent alliances are a certainty before this mobile/tablet war ends.

Wednesday, January 22, 2014

License To Patently Disagree

Today (January 22, 2014), the United States Supreme Court decided Medtronic v. Mirowski, a patent case in which the main issue was whether or not a patentee has the burden of proving patent infringement even when an allegedly-infringing licensee has sued for declaratory judgment of noninfringement.  Here is a summary of the dispute from the syllabus of the Court's decision:
Petitioner Medtronic, Inc., designs, makes, and sells medical devices. Respondent Mirowski Family Ventures, LLC, owns patents relating to implantable heart stimulators. They have a licensing agreement that permits Medtronic to practice certain Mirowski patents in exchange for royalty payments, and that specifies procedures to identify products covered by the license and to resolve disputes between the parties. Pursuant to those procedures, Mirowski notified Medtronic of its belief that several of Medtronic’s products infringed the licensed patents, and Medtronic then challenged that assertion of infringement in a declaratory judgment action, while accumulating disputed royalties in an escrow account for distribution to the prevailing party. The District Court concluded that Mirowski, as the party asserting infringement, had the burden of proving infringement and that Mirowski had not met that burden. The Federal Circuit disagreed. It acknowledged that a patentee normally bears the burden of proof, but concluded that where the patentee is a declaratory judgment defendant and, like Mirowski, is foreclosed from asserting an infringement counterclaim by the continued existence of a licensing agreement, the party seeking the declaratory judgment, namely Medtronic, bears the burden of persuasion
The Court decided in favor of Medtronic, holding that
When a licensee seeks a declaratory judgment against a patentee that its products do not infringe the licensed patent, the patentee bears the burden of persuasion on the issue of infringement.
The Court also nodded to the public policy considerations of its decision, noting that
General considerations relating to the public interest in maintaining a well-functioning patent system are, at most [in this dispute], in balance, and do not favor changing the ordinary burden of proof rule.
In holding that the patentee has the burden of providing infringement, whether it or an allegedly-infringing licensee files suit, the Court found for consistency and against the Court of Appeals for the Federal Circuit.

Patent licensees may now breath more easily as they consider challenging patents they have licensed.  Patent owners are now likely even more carefully to weigh the consequences of alleging that their licensees infringe their patents.

Tuesday, January 21, 2014

Kennedy's Dolphin Hunt Tweet

In 2009, a documentary called "The Cove" brought widespread attention to a dolphin hunt carried out annually in Taiji, Japan.  The film went on to win the 2010 Academy Award for Best Documentary Film.  This year's Taiji dolphin hunt has attracted attention, not just from Sea Shepherd and other conservation and animal rights organizations opposed to the hunt, but even from The U.S. Ambassador to Japan, Caroline Kennedy.  On January 17, 2014, @CarolineKennedy tweeted
Deeply concerned by inhumaneness of drive hunt dolphin killing. USG opposes drive hunt fisheries.
This may be one of the most direct criticisms of a close ally a U.S. Ambassador has ever made about the humane treatment of animals. 

Friday, January 17, 2014

FDA, DNA, & TMI

As discussed earlier on LEXVIVO, on November 22, 2013, the United States Food and Drug Adminstration ("FDA") sent a "WARNING LETTER" sent to 23andme warning that it considers the sequencing and reporting of consumers' genomic information
a device within the meaning of section 201(h) of the [Food, Drug and Cosmetic] Act ["FDCA"], 21 U.S.C. 321(h), because it is intended for use in the diagnosis of disease or other conditions or in the cure, mitigation, treatment, or prevention of disease, or is intended to affect the structure or function of the body.
The FDA asserted its authority to regulate approval and sales of this "device."

On January 15, 2014, in the leading international science journal, Nature, Robert C. Green (Associate Professor of Medicine, Division of Genetics, Brigham and Women’s Hospital and Harvard Medical School, and Associate Director for Research, Partners HealthCare Center for Personalized Genetic Medicine) and Nita Farahany (Director, Science & Society, Duke Institute for Genome Sciences & Policy, Professor, Law and Philosophy, and Professor, Genome Sciences and Policy) published an insightful critique of the FDA's decision to regulate consumer genomics.  They conclude as follows:
We believe that 23andMe should be more transparent about how accurate its genotyping chips are, and even more forthcoming about the limitations of its computer algorithms used for estimations of risk. But regulatory constraints might stifle consumer genomics and other emerging products that could make society healthier and that do not fit neatly into the model of physician-driven health care. The effects of these products should be monitored but, as long as emerging empirical data show no evidence of harm, we urge the FDA to let consumer genomics testing proceed.
The FDA would do well to take notice.

Wednesday, January 15, 2014

Innovation For Productivity

The Conference Board, Inc. ("Board") is a nonprofit that conducts and publishes broadly-based economic research that provides "trusted insights for business worldwide."  In its 2014 Productivity Brief, the Board raises the alarm about worldwide deficiencies in 2013 total factor productivity ("TFP") growth, which it explains as
the result of a combination of improvements in efficiency (fewer inputs are needed for a given output) as well as technology and innovation (more output is achieved from a given input).
In its Brief, the Board reported a remarkable slowdown in TFP growth:
One dramatic result...is that the growth rate of total factor productivity...is less than zero for the global economy.  This indicates a stalling in the efficiency of optimally allocating and using resources.  This stalling appears to be the result of slowing demand in recent years, which caused a drop in productive use of resources that is possibly related to a combination of market rigidities and stagnating innovation.
Market rigidities can be alleviated through reforms to the legal regulation of capital, labor, and taxation regulations.

The problem of "stagnating innovation" is much more difficult to solve.  Technological innovation is crucial to productivity growth, in large part because of its strong effects on production-possibility frontiers.  Even with current patent systems and government research subsidies, technological innovation appears to be lagging.  Perhaps open and user innovation deserve more attention from policymakers as one antidote to this problem.  In the meantime, worldwide productivity and innovation appear to be impeded.